Summary
Amgen Inc. (AMGN) filed an 8-K on July 26, 2012, primarily to report its unaudited financial results for the second quarter and the first half of 2012, ending June 30, 2012. The filing focuses heavily on the company's use of non-GAAP financial measures to provide investors with supplemental information beyond standard U.S. Generally Accepted Accounting Principles (GAAP). These adjustments are intended to offer a clearer view of ongoing operational performance by excluding items such as the impact of stock option expensing, acquisition-related costs, facility transaction expenses, intangible asset amortization, cost-saving initiatives, contingent consideration, legal expenses, and non-cash interest expenses related to convertible notes. Investors should note that Amgen provided these non-GAAP measures to facilitate comparisons across periods, particularly before and after certain expenses were incurred, or to treat acquired intellectual property similarly to internally developed assets. The company also reported Free Cash Flow (FCF) as a non-GAAP measure, calculated as cash flow from operations less capital expenditures, to offer a further perspective on liquidity. The detailed breakdown of these adjustments highlights Amgen's efforts to present a more normalized view of its financial condition and operational profitability.
Key Highlights
- 1Amgen reported its unaudited financial results for the second quarter and first half of 2012 as of June 30, 2012.
- 2The company utilized non-GAAP financial measures extensively, providing adjusted figures for various financial statement line items and earnings per share.
- 3Key adjustments to GAAP measures included excluding stock option expensing, acquisition-related expenses, and expenses related to a transaction with Boehringer Ingelheim (BI) involving its Fremont manufacturing facility.
- 4Amgen also excluded the amortization of acquired product technology rights, cost-saving initiatives, contingent consideration costs, legal expenses, and non-cash interest expense on convertible notes from its adjusted financial results.
- 5The company presented Free Cash Flow (FCF) as a non-GAAP metric, defining it as cash flow from operations minus capital expenditures.
- 6These non-GAAP measures were presented to offer investors supplemental insights and facilitate comparisons across different reporting periods, especially around the incurrence of specific expenses or the existence of convertible notes.
- 7The report includes a press release dated July 26, 2012, as Exhibit 99.1, which contains the detailed financial results and reconciliations.